PRED FORTE

This brand name is authorized in United States. It is also authorized in Canada, Finland, Ireland, Israel, Netherlands, New Zealand, Singapore, Spain, Turkey, UK.

Active ingredients

The drug PRED FORTE contains one active pharmaceutical ingredient (API):

1	Prednisolone UNII 8B2807733D - PREDNISOLONE ACETATE
	Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems.
	Read more about Prednisolone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PRED FORTE Eye drops, suspension	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BA04	Prednisolone	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain
Discover more medicines within S01BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00301175
ES	Centro de información online de medicamentos de la AEMPS	62038
FI	Lääkealan turvallisuus- ja kehittämiskeskus	058552
GB	Medicines & Healthcare Products Regulatory Agency	31518, 31519
IE	Health Products Regulatory Authority	41890
IL	מִשְׂרַד הַבְּרִיאוּת	4507
NL	Z-Index G-Standaard	14843102
NL	Z-Index G-Standaard, PRK	26131
NZ	Medicines and Medical Devices Safety Authority	515
SG	Health Sciences Authority	04661P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699490571040
US	FDA, National Drug Code	11980-180